George Kaiser Family Foundation Purchases Shares of 467 UnitedHealth Group Incorporated (NYSE:UNH)

George Kaiser Family Foundation bought a new position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 467 shares of the healthcare conglomerate's stock, valued at approximately $236,000. UnitedHealth Group comprises 0.0% of George Kaiser Family Foundation's portfolio, making the stock its 17th largest position.

Other large investors have also added to or reduced their stakes in the company. Resolute Advisors LLC purchased a new stake in UnitedHealth Group in the fourth quarter valued at approximately $211,000. Yoffe Investment Management LLC purchased a new stake in shares of UnitedHealth Group in the 4th quarter valued at $1,232,000. Magellan Asset Management Ltd increased its stake in shares of UnitedHealth Group by 2.4% in the fourth quarter. Magellan Asset Management Ltd now owns 635,550 shares of the healthcare conglomerate's stock worth $321,499,000 after acquiring an additional 14,713 shares during the period. Grant Private Wealth Management Inc purchased a new stake in UnitedHealth Group in the fourth quarter valued at $673,000. Finally, Arete Wealth Advisors LLC raised its stake in shares of UnitedHealth Group by 33.6% during the 4th quarter. Arete Wealth Advisors LLC now owns 6,682 shares of the healthcare conglomerate's stock valued at $3,377,000 after buying an additional 1,681 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on UNH. Wells Fargo & Company decreased their price target on UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating for the company in a report on Tuesday, January 28th. Stephens raised their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an "overweight" rating in a research report on Thursday, December 5th. Cantor Fitzgerald reissued an "overweight" rating and set a $700.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Truist Financial lowered their price target on UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating on the stock in a research report on Monday, January 6th. Finally, StockNews.com raised UnitedHealth Group from a "hold" rating to a "buy" rating in a research note on Thursday, January 23rd. Twenty equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat.com, UnitedHealth Group presently has an average rating of "Buy" and an average target price of $629.32.

Remove Ads

UnitedHealth Group Trading Down 2.9 %

Shares of UNH traded down $15.50 during mid-day trading on Friday, reaching $524.94. The stock had a trading volume of 9,914,705 shares, compared to its average volume of 4,261,985. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The firm has a market cap of $480.17 billion, a price-to-earnings ratio of 33.87, a P/E/G ratio of 1.37 and a beta of 0.62. The business's fifty day moving average is $509.24 and its 200 day moving average is $542.37. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company's quarterly revenue was up 6.8% on a year-over-year basis. During the same quarter in the prior year, the company posted $5.83 EPS. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 1.60%. UnitedHealth Group's dividend payout ratio (DPR) is presently 54.19%.

Insiders Place Their Bets

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The shares were acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares of the company's stock, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.33% of the stock is owned by insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.